-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, S6DT/Lxb6pYEYrEDdPzb9Qy6Bz/LJHJuvU3sBcdkO+KImB0ncVTRCYrh8leIVpvV R1Urbt2KcIegyaSnet89gw== 0001012870-98-000359.txt : 19980217 0001012870-98-000359.hdr.sgml : 19980217 ACCESSION NUMBER: 0001012870-98-000359 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980212 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AVIRON CENTRAL INDEX KEY: 0000949173 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 770309686 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-47823 FILM NUMBER: 98535027 BUSINESS ADDRESS: STREET 1: 297 N BERNARDO AVE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 4159196500 MAIL ADDRESS: STREET 1: 297 NORTH BERNARDO AVE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SANG A PHARM CO LTD CENTRAL INDEX KEY: 0001032907 STANDARD INDUSTRIAL CLASSIFICATION: [] STATE OF INCORPORATION: M5 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 640 9 DEUNG CHON DUNG STREET 2: KANGSEO KU SEOUL CITY: SOUTH KOREA BUSINESS PHONE: 4159196500 MAIL ADDRESS: STREET 1: 640 9 DEUNG CHON DUNG STREET 2: KANGSEO KU SEOUL CITY: SOUTH KOREA STATE: M5 SC 13G/A 1 AMENDMENT #1 TO SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G .0000 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 1)* Aviron ------ (Name of Issuer) Common Stock ------------ (Title of Class of Securities) 053762100 --------- (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 6 Pages SCHEDULE 13G ============================================================================== CUSIP NO. 053762100 PAGE 1 OF 6 PAGES ============================================================================== ============================================================================== NAME OF REPORTING PERSON 1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Sang-A Pharm. Co. Ltd. - ------------------------------------------------------------------------------ CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* 2 (a) [_] (b) [_] - ------------------------------------------------------------------------------ SEC USE ONLY 3 - ------------------------------------------------------------------------------ CITIZENSHIP OR PLACE OF ORGANIZATION 4 South Korea - ------------------------------------------------------------------------------ SOLE VOTING POWER 5 NUMBER OF 1,065,031 SHARES ----------------------------------------------------------- SHARED VOTING POWER BENEFICIALLY 6 0 OWNED BY ----------------------------------------------------------- EACH SOLE DISPOSITIVE POWER 7 REPORTING 1,065,031 PERSON ----------------------------------------------------------- SHARED DISPOSITIVE POWER WITH 8 0 - ------------------------------------------------------------------------------ AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9 1,065,031 - ------------------------------------------------------------------------------ CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* 10 - ------------------------------------------------------------------------------ PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 11 6.6 - ------------------------------------------------------------------------------ TYPE OF REPORTING PERSON* 12 OO ============================================================================== *SEE INSTRUCTIONS BEFORE FILLING OUT! Page 2 of 6 pages SCHEDULE 13G ITEM 1. (a) NAME OF ISSUER: Aviron (b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICE: 297 North Bernardo Avenue Mountain View, CA 94043 ITEM 2. (a) NAME OF PERSON FILING: Sang-A Pharm. Co. Ltd. (b) ADDRESS OF PRINCIPAL BUSINESS OFFICES OR, IF NONE, Residence: 640-9 Deung Chon Dung Kangsea-Ku, Seoul South Korea (c) CITIZENSHIP: South Korea (d) TITLE OF CLASS OF SECURITIES: Common Stock (e) CUSIP NUMBER: 053762100 Page 3 of 6 Pages ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), OR 13d-2(b), CHECK WHETHER THE PERSON FILING IS A: Not Applicable ITEM 4. OWNERSHIP: (a) AMOUNT BENEFICIALLY OWNED: 1,065,031 (b) PERCENT OF CLASS: 6.6 (c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS: (i) sole power to vote or direct the vote 1,065,031 (ii) shared power to vote or to direct the vote 0 (iii) sole power to dispose or to direct the disposition of 1,065,031 (iv) shared power to dispose or to direct the disposition of 0 Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: Not Applicable ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON: Not Applicable Page 4 of 6 Pages ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY: Not Applicable ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP: Not Applicable ITEM 9. NOTICE OF DISSOLUTION OF GROUP: Not Applicable ITEM 10. CERTIFICATION: Not Applicable Page 5 of 6 Pages SIGNATURE After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Dated: February 11, 1998. /s/ Alan C. Mendelson ----------------------------------- Alan C. Mendelson, Attorney-in-fact Page 6 of 6 Pages -----END PRIVACY-ENHANCED MESSAGE-----